First Trust Active Factor... (AFSM)
Bid | 26.7 |
Market Cap | 39.28M |
AUM | 41.41M |
NAV | 31.85 |
EPS (ttm) | 2.10 |
PE Ratio (ttm) | 14.93 |
Shares Out | 1.25M |
Inception Date | Dec 3, 2019 |
Ask | 31.39 |
Volume | 1.02K |
Open | 31.41 |
Previous Close | 31.20 |
Day's Range | 31.36 - 31.41 |
52-Week Range | 24.42 - 33.51 |
Holdings | 309 |
Expense Ratio | 0.75% |
About AFSM
The First Trust Active Factor Small Cap ETF seeks to provide capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its net assets (including investment borrowings) in U.S.-listed equity securities issued by small capitalization companies. The Fund is actively managed primarily relying on a multi-factor quantitative methodology with active risk management to construct a portfolio of securities exhibiting exposures to one or more investing factors. The multi-factor quantitative methodology currently used by the Fund may take into account the following factors: (i) value; (ii) momentum; (iii) quality; and (iv) low volatility.
Top Sectors
Sector | Weight % |
---|---|
Financial Services | 17.82% |
Technology | 16.56% |
Industrials | 16.01% |
Healthcare | 15.85% |
Consumer Cyclical | 11.28% |
Top 10 Holdings 9.36% of assets
Name | Symbol | Weight |
---|---|---|
Carpenter Technology... | CRS | 1.52% |
Halozyme Therapeutic... | HALO | 1.03% |
Cal-maine Foods, Inc... | CALM | 0.96% |
Corcept Therapeutics... | CORT | 0.91% |
Interdigital, Inc. | IDCC | 0.89% |
Sprouts Farmers Mark... | SFM | 0.89% |
Adma Biologics, Inc. | ADMA | 0.86% |
Rev Group, Inc. | REVG | 0.78% |
Catalyst Pharmaceuti... | CPRX | 0.76% |
Applied Industrial T... | AIT | 0.76% |
Dividends Dividend Yield 0.7%
Ex-Dividend | Amount | Payment Date |
---|---|---|
Jun 26, 2025 | $0.0569 | Jun 30, 2025 |
Mar 27, 2025 | $0.0531 | Mar 31, 2025 |
Dec 13, 2024 | $0.0825 | Dec 31, 2024 |
Sep 26, 2024 | $0.0165 | Sep 30, 2024 |
Jun 27, 2024 | $0.0478 | Jun 28, 2024 |

5 months ago · seekingalpha.com
Why Is The IPO Market Struggling? Here's What Active Managers Have To SayStrong returns in U.S. stocks, particularly over the past two plus years, have led investors to question the relative lack of companies going public via the IPO process — as well as the potential impl...